Pulse 탐색 nav.journalClub 토론 트렌드 연구자 저널

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

March 8, 2019Open Access

노인 환자의 교모세포종: 현재 관리와 미래 전망

GMGiuseppe MinnitiPoliclinico Umberto I GLGiuseppe LombardiUniversity of Pisa SPSergio PaoliniIstituto Neurologico Mediterraneo

Key Points

Key points are not available for this paper at this time.

Abstract

) 유전자 프로모터는 향후 시험에서 탐구되어야 합니다.

AI에게 질문

Like

Bookmark

Share

View Full Paper

AI에게 질문

Like

Bookmark

Share

View Full Paper

Cite This Study

Minniti et al. (금요일,)은 이 질문을 연구했습니다.

synapsesocial.com/papers/6a0214e2f58f6e6cfdd8d687 https://doi.org/https://doi.org/10.3390/cancers11030336

노인 환자에서의 교모세포종: 현재 관리 및 미래 전망 | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Phase II Study of Short-Course Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Elderly Patients With Glioblastoma2011 · 131 citations
2AGE-RELATED CHEMOSENSITIVITY OF STEM CELLS FROM HUMAN MALIGNANT BRAIN TUMOURS1982 · 78 citations
3The Limited Value of Cytoreductive Surgery in Elderly Patients with Malignant Gliomas1994 · 119 citations
4A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme1994 · 164 citations
5Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial2012 · 1,277 citations